ASMBAssembly Biosciences, Inc.
Is it growing?
Neither accelerating nor breaking down: revenue growing +125% year on year and operating margin widening (+74.4 points), but earnings down −118% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, -60.0% now against -134.4% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is ASMB growing?
- Revenue growth, 5-year rate
- −1.8%
Revenue growth, 5-year rate
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $6.3M
- Revenue FY2022
- $0
- Revenue FY2023
- $7.2M
- Revenue FY2024
- $29M
- Revenue FY2025
- $72M
Annual income statements as filed with the SEC.